Abstract
No one would dispute that intracellular enzymes such as kinases and phosphatases play critical roles in regulating the development, activation, differentiation, and survival of lymphocytes1. However, it is less well appreciated that cells of the immune system also express many membrane-associated ecto-enzymes that have the potential to regulate immune cell function. Ecto-enzymes have their active sites located on the outside of the cell and therefore must utilize substrates that are found in the extracellular milieu. Some of these enzymes, such as CD26, act as peptidases, while others, including CD73, CD38, CD39, ART2, and PC-1, utilize nucleotides as substrates. Although it was proposed that these nucleotide-utilizing enzymes might be involved in salvaging purines2 or in generating products such as ATP, ADP, and adenosine that function as signaling molecules for purinergic receptors3, until recently very little was known about the functional roles these enzymes might play during immune responses. However, in the last 10 years it has become clear that many of these enzymes play very important roles in regulating the survival, activation, and effector function of leukocytes4. Our laboratory has spent the last several years assessing the role of one of these ectoenzymes, CD38, in immune responses. In this article, we will review our recent work, focusing on the role that CD38 plays in regulating innate and adaptive immune responses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
6. References
J.L. Cannons and P.L. Schwartzberg. Fine-tuning lymphocyte regulation: what’s new with tyrosine kinases and phosphatases? Curr Opin Immunol 16:296–303 (2004).
P. Deterre, L. Gelman, H. Gary-Gouy, C. Arrieumerlou, V. Berthelier, J.-M. Tixier, S. Ktorza, J. Goding, C. Schmitt and G. Bismuth. Coordinated regulation in human T cells of nucleotide-hydrolyzing ecto-enzymatic activities, including CD38 and PC-1. J Immunol 157:1381–1388 (1996).
R. Resta, Y. Yamashita and L.F. Thompson. Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol Rev 161:95–109 (1998).
M. Salmi and S. Jalkanen. Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol 5:760–771 (2005).
F. Schuber and F.E. Lund. Structure and enzymology of ADP-ribosyl cyclases: conserved enzymes that produce multiple calcium mobilizing metabolites. Curr Mol Med 4:249–261 (2004).
H.C. Lee and R. Aarhus. ADP-ribosyl cyclase: an enzyme that cyclizes NAD+ into a calcium mobilizing metabolite. Cell Regul 2:203–209 (1991).
M.R. Hellmich and F. Strumwasser. Purification and characterization of a molluscan egg-specific NADase, a second-messenger enzyme. Cell Regul 2:193–202 (1991).
S.P. Goodrich, H. Muller-Steffner, A. Osman, M.J. Moutin, K. Kusser, A. Roberts, D.L. Woodland, T.D. Randall, E. Kellenberger, P.T. LoVerde, F. Schuber and F.E. Lund. Production of calcium-mobilizing metabolites by a novel member of the ADP-ribosyl cyclase family expressed in Schistosoma mansoni. Biochemistry 44:11082–11097 (2005).
D.G. Jackson and J.I. Bell. Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation. J Immunol 144:2811–2815 (1990).
H.C. Lee. Multiplicity of Ca2+ messengers and Ca2+ stores: a perspective from cyclic ADP-ribose and NAADP. Curr Mol Med 4:227–237 (2004).
F.J. Kuhn, I. Heiner and A. Luckhoff. TRPM2: a calcium influx pathway regulated by oxidative stress and the novel second messenger ADP-ribose. Pflugers Arch 451:212–219 (2005).
A.H. Guse. Regulation of calcium signaling by the second messenger cyclic adenosine diphosphoribose (cADPR). Curr Mol Med 4:239–248 (2004).
J.E. Fernandez, S. Deaglio, D. Donati, I.S. Beusan, F. Corno, A. Aranega, M. Forni, B. Falini and F. Malavasi. Analysis of the distribution of human CD38 and of its ligand CD31 in normal tissues. J Biol Reg Homeost Agents 12:81–91 (1998).
F. Malavasi, A. Funaro, M. Alessio, L.B. De Monte, C.M. Ausiello, U. Dianzani, F. Lanza, E. Magrini, M. Momo and S. Roggero. CD38: a multi-lineage cell activation molecule with a split personality. Int J Clin Lab Res 22:73–80 (1992).
T. Musso, S. Deaglio, L. Franco, L. Calosso, R. Badolato, G. Garbarino, U. Dianzani and F. Malavasi. CD38 expression and functional activities are up-regulated by IFN-g on human monocytes and monocytic cell lines. J Leukoc Biol 69:605–612 (2001).
B. Bauvois, L. Durant, J. Laboureau, E. Barthelemy, D. Rouillard, G. Boulla and P. Deterre. Upregulation of CD38 gene expression in leukemic B cells by interferon types I and II. J Interferon Cytokine Res 19:1059–1066 (1999).
D. Cockayne, T. Muchamuel, J.C. Grimaldi, H. Muller-Steffner, T.D. Randall, F.E. Lund, R. Murray, F. Schuber and M.C. Howard. Mice deficient for the ecto-NAD+ glycohydrolase CD38 exhibit altered humoral immune responses. Blood 92:1324–1333 (1998).
F.E. Lund, D.A. Cockayne, T.D. Randall, N. Solvason, F. Schuber and M.C. Howard. CD38: A new paradigm in lymphocyte activation and signal transduction. Immunol Rev 161:79–93 (1998).
S. Partida-Sanchez, S. Goodrich, K. Kusser, N. Oppenheimer, T.D. Randall and F.E. Lund. Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: Impact on the development of humoral immunity. Immunity 20:279–291 (2004).
S. Partida-Sanchez, T.D. Randall and F.E. Lund. Innate immunity is regulated by CD38. an ecto-enzyme with ADP-ribosyl cyclase activity. Microbes Infect 5:49–58 (2003).
S. Partida-Sanchez, D.A. Cockayne, S. Monard, E.L. Jacobson, N. Oppenheimer, B. Garvy, K. Kusser, S. Goodrich, M. Howard, A. Harmsen, T.D. Randall and F.E. Lund. Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo. Nat Med 7:1209–1216 (2001).
S. Partida-Sanchez, P. Iribarren, M.E. Moreno-Garcia, J.-L. Gao, P.M. Murphy, N. Oppenheimer, J.M. Wang and F.E. Lund. Chemotaxis and calcium responses of phagocytes to formyl-peptide receptor ligands is differentially regulated by cyclic ADP-ribose. J Immunol 172:1896–1906 (2004).
G.J. Randolph, G. Sanchez-Schmitz and V. Angeli. Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances. Springer Semin Immunopathol 26:273–287 (2005).
M.D. Gunn, S. Kyuwa, C. Tam, T. Kakiuchi, A. Matsuzawa, L.T. Williams and H. Nakano. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 189:451–460 (1999).
R. Forster, A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Muller, E. Wolf and M. Lipp. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23–33 (1999).
M. Merad, M.G. Manz, H. Karsunky, A. Wagers, W. Peters, I. Charo, I.L. Weissman, J.G. Cyster and E.G. Engleman. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 3:1135–1141 (2002).
H.C. Lee. Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers. Annu Rev Pharmacol Toxicol 41:317–345 (2001).
E. Hosoi, C. Nishizaki, K.L. Gallagher, H.W. Wyre, Y. Matsuo and Y. Sei. Expression of the ryanodine receptor isoforms in immune cells. J Immunol 167:4887–4894 (2001).
H. Muller-Steffner, O. Malver, N.J. Oppenheimer and F. Schuber. Slow-binding inhibition of NAD+ glycohydrolase by arabino analogues of b-NAD+. J Biol Chem 267:9606–9611 (1992).
S. Deaglio and F. Malavasi. Human CD38: a receptor, an (ecto) enzyme, a disease marker and lots more. Mod Asp Immunobiol 2:121–125 (2002).
S. Deaglio, U. Dianzani, A.L. Horenstein, J.E. Fernandez, C. van Kooten, M. Bragardo, A. Funaro, G. Garbarino, F. Di Virgilio, J. Bancherau and F. Malavasi. Human CD38 ligand: a 120-kDA protein predominantly expressed on endothelial cells. J Immunol 156:727–734 (1996).
S. Deaglio, M. Morra, R. Mallone, C.M. Ausiello, E. Prager, G. Garbarino, U. Dianzani, H. Stockinger and F. Malavasi. Human CD38 (ADP-Ribosyl Cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol 160:395–402 (1998).
F.E. Lund, T.D. Randall and S. Partida-Sanchez. Cyclic ADP-ribose and NAADP. In Structures, metabolism and function, Vol. 1, pp. 217–240. Ed. H.C. Lee. New York: Kluwer Academic (2002).
H. Nishina, K. Inageda, K. Takahashi, S. Hoshino, K. Ikeda and T. Katada. Cell surface antigen CD38 identified as ecto-enzyme of NAD glycohydrolase has hyaluronate-binding activity. Biochem Biophys Res Comm 203:1318–1323 (1994).
Q. Liu, I.A. Kriksunov, R. Graeff, C. Munshi, H.C. Lee and Q. Hao. Crystal structure of human CD38 extracellular domain. Structure (Cambridge) 13:1331–1339 (2005).
C. Munshi, R. Aarhus, R. Graeff, T.F. Walseth, D. Levitt and H.C. Lee. Identification of the enzymatic active site of CD38 by site-directed mutagenesis. J Biol Chem 275:21566–21571 (2000).
U.H. Kim, M.K. Kim, J.S. Kim, M.K. Han, B.H. Park and H.R. Kim. Purification and characterization of NAD glycohydrolase from rabbit erythrocytes. Arch Biochem Biophys 305:147–152 (1993).
M. Seman, S. Adriouch, F. Haag and F. Koch-Nolte. Ecto-ADP-ribosyltransferases (ARTs): emerging actors in cell communication and signaling. Curr Med Chem 11:857–872 (2004).
G.M. Barton and R. Medzhitov. Toll-like receptors and their ligands. Curr Top Microbiol Immunol 270:81–92 (2002).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this paper
Cite this paper
Partidá-Sánchez, S., Rivero-Nava, L., Shi, G., Lund, F.E. (2007). CD38: An Ecto-Enzyme at the Crossroads of Innate and Adaptive Immune Responses. In: Katsikis, P.D., Schoenberger, S.P., Pulendran, B. (eds) Crossroads between Innate and Adaptive Immunity. Advances in Experimental Medicine and Biology, vol 590. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-34814-8_12
Download citation
DOI: https://doi.org/10.1007/978-0-387-34814-8_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-34813-1
Online ISBN: 978-0-387-34814-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)